Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A phosphodiesterase inhibitor is a drug that blocks one or more of the five subtypes of the enzyme phosphodiesterase (PDE), thereby preventing the inactivation of the intracellular second messengers cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) by the respective PDE subtype(s).
PDE inhibitor drugs are also used to treat various other medical conditions such as autoimmune indications, ulcerative colitis, and others. However, the increasing incidence of ED across the world will boost the global phosphodiesterase inhibitors market growth during the forecast period.
The report details the trend, potential and market size of Phosphodiesterase (PDE) inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Phosphodiesterase (PDE) inhibitorsmarket, defines the market attractiveness level of Phosphodiesterase (PDE) inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Phosphodiesterase (PDE) inhibitors industry, describes the types of Phosphodiesterase (PDE) inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Phosphodiesterase (PDE) inhibitors market and the development prospects and opportunities of Phosphodiesterase (PDE) inhibitors industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Phosphodiesterase (PDE) inhibitors market in Chapter 13.
By Player:
Eli Lilly and Co
Bayer AG
Pfizer Inc
GlaxoSmithKline Plc
Vivus Inc
By Type:
PDE1 Selective Inhibitors
PDE2 Selective Inhibitors
PDE3 Selective Inhibitors
PDE4 selective inhibitors
PDE5 selective inhibitors
PDE7 selective inhibitors
PDE10 selective inhibitors
By End-User:
Oral
Topical
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Phosphodiesterase (PDE) inhibitors Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Phosphodiesterase (PDE) inhibitors Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Phosphodiesterase (PDE) inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Phosphodiesterase (PDE) inhibitors Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Phosphodiesterase (PDE) inhibitors Market Analysis and Outlook to 2022
-
7.1 Global Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.2 United States Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.3 Europe Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.4 China Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.5 Japan Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.6 India Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
-
7.7 South Korea Phosphodiesterase (PDE) inhibitors Consumption (2017-2022)
8 Region and Country-wise Phosphodiesterase (PDE) inhibitors Market Analysis and Outlook to 2028
-
8.1 Global Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.2 United States Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.3 Europe Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.4 China Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.5 Japan Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.6 India Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
-
8.7 South Korea Phosphodiesterase (PDE) inhibitors Consumption Forecast (2022-2028)
9 Global Phosphodiesterase (PDE) inhibitors Market Outlook by Types and Applications to 2022
-
9.1 Global Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PDE1 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PDE2 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global PDE3 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global PDE4 selective inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global PDE5 selective inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.6 Global PDE7 selective inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.7 Global PDE10 selective inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Phosphodiesterase (PDE) inhibitors Market Outlook by Types and Applications to 2028
-
10.1 Global Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global PDE1 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PDE2 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global PDE3 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global PDE4 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global PDE5 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global PDE7 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global PDE10 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Phosphodiesterase (PDE) inhibitors Import and Export Analysis (Top 5 Countries)
-
11.1 Global Phosphodiesterase (PDE) inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Phosphodiesterase (PDE) inhibitors Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Phosphodiesterase (PDE) inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Phosphodiesterase (PDE) inhibitors Market Competitive Analysis
-
14.1 Eli Lilly and Co
-
14.1.1 Eli Lilly and Co Company Details
-
14.1.2 Eli Lilly and Co Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Co Phosphodiesterase (PDE) inhibitors Product and Service
-
14.2 Bayer AG
-
14.2.1 Bayer AG Company Details
-
14.2.2 Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer AG Phosphodiesterase (PDE) inhibitors Product and Service
-
14.3 Pfizer Inc
-
14.3.1 Pfizer Inc Company Details
-
14.3.2 Pfizer Inc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer Inc Phosphodiesterase (PDE) inhibitors Product and Service
-
14.4 GlaxoSmithKline Plc
-
14.4.1 GlaxoSmithKline Plc Company Details
-
14.4.2 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product and Service
-
14.5 Vivus Inc
-
14.5.1 Vivus Inc Company Details
-
14.5.2 Vivus Inc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Vivus Inc Phosphodiesterase (PDE) inhibitors Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Phosphodiesterase (PDE) inhibitors
-
Figure Phosphodiesterase (PDE) inhibitors Picture
-
Table Global Phosphodiesterase (PDE) inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Phosphodiesterase (PDE) inhibitors Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Phosphodiesterase (PDE) inhibitors Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Phosphodiesterase (PDE) inhibitors Consumption by Country (2017-2022)
-
Figure United States Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Table Europe Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure China Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Japan Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure India Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure South Korea Phosphodiesterase (PDE) inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Phosphodiesterase (PDE) inhibitors Consumption Forecast by Country (2022-2028)
-
Figure United States Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Phosphodiesterase (PDE) inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE1 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE2 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE3 Selective Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE4 selective inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE5 selective inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE7 selective inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global PDE10 selective inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global PDE1 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE2 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE3 Selective Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE4 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE5 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE7 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE10 selective inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Phosphodiesterase (PDE) inhibitors Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Phosphodiesterase (PDE) inhibitors Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Co (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Co Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Co Phosphodiesterase (PDE) inhibitors Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Phosphodiesterase (PDE) inhibitors Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Phosphodiesterase (PDE) inhibitors Product and Service
-
Table GlaxoSmithKline Plc (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Plc Phosphodiesterase (PDE) inhibitors Product and Service
-
Table Vivus Inc (Foundation Year, Company Profile and etc.)
-
Table Vivus Inc Phosphodiesterase (PDE) inhibitors Sales, Price, Value and Gross Profit (2017-2022)
-
Table Vivus Inc Phosphodiesterase (PDE) inhibitors Product and Service
-
